Announcements Trials
Browse Landscape

Status

Completed 3Unknown 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Breast 3Lymphoid 2CNS 2Plasma cell 1Other hematologic neoplasm 1Genitourinary 1Dermatologic 1

Conditions

Prostatic Neoplasms 957Urinary Bladder Neoplasms 264Carcinoma, Renal Cell 251Kidney Neoplasms 147Carcinoma, Transitional Cell 129Breast Neoplasms 127Neoplasms 122Colorectal Neoplasms 97Ovarian Neoplasms 90Melanoma 85Carcinoma, Non-Small-Cell Lung 84Lung Neoplasms 81Neoplasm Metastasis 79Pancreatic Neoplasms 68Non-Muscle Invasive Bladder Neoplasms 68Uterine Cervical Neoplasms 58Stomach Neoplasms 55Head and Neck Neoplasms 51Squamous Cell Carcinoma of Head and Neck 47Endometrial Neoplasms 47Adenocarcinoma 45Esophageal Neoplasms 44Testicular Neoplasms 42Carcinoma, Hepatocellular 41Sarcoma 39Disease 33Triple Negative Breast Neoplasms 32Liver Neoplasms 30Colonic Neoplasms 29Metastatic Castration-resistant Prostate Cancer 25

Interventions

CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Drug-Related Side Effects and Adverse Reactions × Genitourinary × Clear all
NCT04659343 2026-05-04

TDM for Optimized Outcome in Patients With mRCC.

University of Aarhus

Recruiting
200 enrolled
Genitourinary

Kidney Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡